You have 6 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

psoriasis plaques test

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriasis Trial in Fargo, Philadelphia (Drug (SFA002) Vitamin D, Magnesium, Drug (SFA002) Vitamin D, Magnesium and Propionate)

Recruiting
  • Psoriasis
  • Drug (SFA002) Vitamin D, Magnesium
  • Drug (SFA002) Vitamin D, Magnesium and Propionate
  • Fargo, North Dakota
  • +1 more
Dec 9, 2022

Identifying Vulnerable CoronAry PLaqUes With Artificial

Enrolling by invitation
  • Coronary Artery Disease
  • Plaque, Atherosclerotic
  • Intravascular imaging test
  • Nanjing, Jiangsu, China
    Research Institute Of Medical Imaging Jinling Hospital
Sep 5, 2023

Incretin Effect in Patients With Psoriasis and Controls

Completed
  • Psoriasis Vulgaris
  • Oral glucose tolerance test
  • +2 more
  • (no location specified)
Sep 28, 2023

Generalized Pustular Psoriasis Trial (Spesolimab)

Not yet recruiting
  • Generalized Pustular Psoriasis
  • (no location specified)
Sep 4, 2023

Psoriasis Trial (BI 765250, Placebo)

Not yet recruiting
  • Psoriasis
  • BI 765250
  • Placebo
  • (no location specified)
Feb 6, 2023

Plaque Psoriasis Trial in Cairo (Bee venom phonophoresis)

Not yet recruiting
  • Plaque Psoriasis
  • Bee venom phonophoresis
  • Cairo, Egypt
    Ahmed Mohamed Ahmed Abdelhady
Oct 31, 2023

Psoriasis Vulgaris Trial in Bergmannstrasse 5 (AKVANO-Calcipotriol formulation 1, AKVANO-Calcipotriol formulation 2, AKVANO

Completed
  • Psoriasis Vulgaris
  • AKVANO-Calcipotriol formulation 1
  • +5 more
  • Bergmannstrasse 5, Berlin, Germany
    bioskin GmbH
Aug 3, 2022

Chronic Plaque-type Psoriasis Trial in Canada, Germany, United States (Skin biopsies)

Completed
Has Results
  • Chronic Plaque-type Psoriasis
  • Skin biopsies
  • New Orleans, Louisiana
  • +13 more
Oct 7, 2021

Psoriasis Trial in Canada, Germany, United States (BI 730357, Placebo to match BI 730357)

Terminated
Has Results
  • Psoriasis
  • BI 730357
  • Placebo to match BI 730357
  • Birmingham, Alabama
  • +29 more
Oct 27, 2022

Plaque Psoriasis Trial in Charlotte (Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%, Duobrii® Lotion (Halobetasol

Completed
  • Plaque Psoriasis
  • Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045%
  • +2 more
  • Charlotte, North Carolina
    Catawba Research, LLC
Mar 15, 2022

Psoriatic Nail, Psoriasis Vulgaris, Psoriasis Trial in Birmingham (Apremilast)

Completed
Has Results
  • Psoriatic Nail
  • +2 more
  • Birmingham, Alabama
    The Kirklin Clinic
Sep 29, 2022

Moderate to Severe Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis Trial in Japan (Placebo, Certolizumab

Completed
Has Results
  • Moderate to Severe Psoriasis
  • Generalized Pustular Psoriasis and Erythrodermic Psoriasis
  • Placebo
  • Certolizumab Pegol
  • Asahikawa, Japan
  • +32 more
Dec 13, 2021

Predicting Medication Response for Autoimmune Disease

Recruiting
  • Ulcerative Colitis
  • +3 more
  • Coral FRS test
  • San Francisco, California
    Coral Genomics, Inc.
Jul 30, 2021

Hormonal Associations in Male Patients With Psoriasis Vulgaris

Not yet recruiting
  • Psoriasis Vulgaris
  • Morning blood sample and skin punch biopsy of 4 mm diameter.
  • (no location specified)
Feb 3, 2023

Psoriasis Vulgaris Trial (SDD formula, Placebo)

Not yet recruiting
  • Psoriasis Vulgaris
  • SDD formula
  • Placebo
  • (no location specified)
Apr 4, 2023

Psoriasis Trial in Montpellier, Nîmes (Generic antiretroviral)

Recruiting
  • Psoriasis
  • Generic antiretroviral
  • Montpellier, France
  • +1 more
Jun 18, 2021

Psoriasis, Gluten Sensitivity Trial in Palermo (Open wheat challenge, Placebo challenge)

Not yet recruiting
  • Psoriasis
  • Gluten Sensitivity
  • Open wheat challenge
  • Placebo challenge
  • Palermo, PA, Italy
  • +2 more
Nov 30, 2022

Subclinical Atherosclerosis in Psoriasis

Active, not recruiting
  • Psoriasis
  • Atherosclerosis
    • Madrid, Spain
      Ramón y Cajal University Hospital
    May 4, 2023

    Psoriasis Trial (Inflammatory skin disease formula, Placebo)

    Not yet recruiting
    • Psoriasis
    • Inflammatory skin disease formula
    • Placebo
    • (no location specified)
    Oct 18, 2022

    Plaque Psoriasis Trial in Karachi (Secukinumab Injection)

    Completed
    • Plaque Psoriasis
    • Secukinumab Injection
    • Karachi, Sindh, Pakistan
      Jinnah Post graduate Medical centre
    Jun 4, 2023

    Generalized Pustular Psoriasis Trial in Worldwide (Spesolimab, Placebo)

    Completed
    Has Results
    • Generalized Pustular Psoriasis
    • Birmingham, Alabama
    • +36 more
    Feb 11, 2022

    Generalized Pustular Psoriasis Trial in Worldwide (Spesolimab)

    Recruiting
    • Generalized Pustular Psoriasis
    • Auburn Hills, Michigan
    • +49 more
    Aug 22, 2022

    Psoriasis Trial in Sohag (skin biopsy)

    Not yet recruiting
    • Psoriasis
    • skin biopsy
    • Sohag, Egypt
      Sohag university Hospital
    Sep 21, 2023

    Psoriasis Vulgaris Trial in High Point (0.01% Halobetasol, 0.045% Tazarotene, 0.05% Clobetasol Propionate)

    Active, not recruiting
    • Psoriasis Vulgaris
    • 0.01% Halobetasol
    • +2 more
    • High Point, North Carolina
      Dermatology Consulting Services, PLLC
    Sep 16, 2023

    Psoriasis Vulgaris, Fractional CO2 Laser Trial in Assiut (Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone

    Completed
    • Psoriasis Vulgaris
    • Fractional CO2 Laser
    • Topical Ointment containing Calcipotriol 0.05 mg/gm and Betamethasone dipropionate 0.5 mg/gm
    • Fractional carbon dioxide (CO2) laser
    • Assiut, Egypt
      Assiut University
    Aug 23, 2023